In consultation with the Member States and the parties concerned, the Commission shall draw up and publish detailed guidance concerning in particular:

1. (a)

   the wording of certain special warnings for certain categories of medicinal products;

2. (b)

   the particular information needs relating to non-prescription medicinal products;

3. (c)

   the legibility of particulars on the labelling and package leaflet;

4. (d)

   the methods for the identification and authentication of medicinal products;

5. (e)

   the list of excipients which must feature on the labelling of medicinal products and the way in which these excipients must be indicated;

6. (f)

   harmonised provisions for the implementation of Article 57.